[Treatment of duodenal ulcer with a new bicyclic compound: prindamin. A double-blind controlled trial]. 1977

H R Wulff, and J Soltoft, and E Gudmand-Hoyer, and K M Molmann, and O Bonnevie, and H E Petersen, and K F Overo

UI MeSH Term Description Entries
D007189 Indans Aryl CYCLOPENTANES that are a reduced (protonated) form of INDENES. Indanones
D007192 Indenes A family of fused-ring hydrocarbons isolated from coal tar that act as intermediates in various chemical reactions and are used in the production of coumarone-indene resins.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D011437 Propylamines Derivatives of propylamine (the structural formula NH2CH2CH2CH3).
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004381 Duodenal Ulcer A PEPTIC ULCER located in the DUODENUM. Curling's Ulcer,Curling Ulcer,Curlings Ulcer,Duodenal Ulcers,Ulcer, Curling,Ulcer, Duodenal,Ulcers, Duodenal

Related Publications

H R Wulff, and J Soltoft, and E Gudmand-Hoyer, and K M Molmann, and O Bonnevie, and H E Petersen, and K F Overo
January 1982, Scandinavian journal of gastroenterology. Supplement,
H R Wulff, and J Soltoft, and E Gudmand-Hoyer, and K M Molmann, and O Bonnevie, and H E Petersen, and K F Overo
April 1988, Chinese medical journal,
H R Wulff, and J Soltoft, and E Gudmand-Hoyer, and K M Molmann, and O Bonnevie, and H E Petersen, and K F Overo
December 1985, Singapore medical journal,
H R Wulff, and J Soltoft, and E Gudmand-Hoyer, and K M Molmann, and O Bonnevie, and H E Petersen, and K F Overo
May 1993, Scandinavian journal of gastroenterology,
H R Wulff, and J Soltoft, and E Gudmand-Hoyer, and K M Molmann, and O Bonnevie, and H E Petersen, and K F Overo
April 1968, Journal of the Indian Medical Association,
H R Wulff, and J Soltoft, and E Gudmand-Hoyer, and K M Molmann, and O Bonnevie, and H E Petersen, and K F Overo
December 1974, International journal of clinical pharmacology, therapy and toxicology,
H R Wulff, and J Soltoft, and E Gudmand-Hoyer, and K M Molmann, and O Bonnevie, and H E Petersen, and K F Overo
February 1979, Gastroenterology,
H R Wulff, and J Soltoft, and E Gudmand-Hoyer, and K M Molmann, and O Bonnevie, and H E Petersen, and K F Overo
July 1979, British medical journal,
H R Wulff, and J Soltoft, and E Gudmand-Hoyer, and K M Molmann, and O Bonnevie, and H E Petersen, and K F Overo
December 1981, Hepato-gastroenterology,
H R Wulff, and J Soltoft, and E Gudmand-Hoyer, and K M Molmann, and O Bonnevie, and H E Petersen, and K F Overo
October 1976, Il Farmaco; edizione pratica,
Copied contents to your clipboard!